sydney6791,
This is the problem when people become very loose with the figures they quote that are NOT qualified!
The ~$6B for the Asian market is for ALL of the blood processes. This includes the market that NuSep does NOT PLAN to participate in.
Please do not use figures loosely as it imparts incorrect information to existing and 'potential' shareholders - provided management gets it right.
They will not get it right until such time as they acknowledge they have not been meeting their obligations to their shareholders AND of course they get the operation up and running in Singapore.
Of course, it is also important to ensure they follow through with all the other plans they started and don't let them fall by the wayside!
Regards....................
Ann: Research Report on NuSep , page-9
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $13.00M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.6¢ | 0.5¢ | $49.30K | 9.656M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 2234999 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 5372603 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| MEM (ASX) Chart |
